Log in

Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant

  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  • Allgrove J (1997) Bisphosphonates. Arch Dis Child 76: 73-75.

    Google Scholar 

  • Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339: 947-952.

    Google Scholar 

  • Plotkin H, Rauch F, Bishop NJ, et al (2000) Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 85: 1846-1850.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W.-L. Hwu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chien, YH., Chu, SY., Hsu, CC. et al. Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant. J Inherit Metab Dis 25, 593–595 (2002). https://doi.org/10.1023/A:1022099425316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022099425316

Navigation